VBIV Annual CFO
-$60.88 M
+$12.81 M+17.39%
31 December 2023
Summary:
As of February 5, 2025, VBIV annual cash flow from operations is -$60.88 million, with the most recent change of +$12.81 million (+17.39%) on December 31, 2023. During the last 3 years, it has fallen by -$13.83 million (-29.40%).VBIV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly CFO
-$11.77 M
+$287.00 K+2.38%
31 March 2024
Summary:
As of February 5, 2025, VBIV quarterly cash flow from operations is -$11.77 million, with the most recent change of +$287.00 thousand (+2.38%) on March 31, 2024. Over the past year, it has increased by +$7.44 million (+38.73%).VBIV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM CFO
-$51.00 M
+$9.89 M+16.24%
31 March 2024
Summary:
As of February 5, 2025, VBIV TTM cash flow from operations is -$51.00 million, with the most recent change of +$9.89 million (+16.24%) on March 31, 2024. Over the past year, it has increased by +$26.19 million (+33.93%).VBIV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.4% | +38.7% | +33.9% |
| 3 y3 years | -29.4% | +38.2% | +30.8% |
| 5 y5 years | -33.7% | +38.2% | +30.8% |
VBIV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -6802.7% | <-9999.0% |
VBI Vaccines Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$11.77 M(-2.4%) | -$51.00 M(-16.2%) |
| Dec 2023 | -$60.88 M(-17.4%) | -$12.06 M(+51.5%) | -$60.88 M(-10.3%) |
| Sept 2023 | - | -$7.96 M(-58.6%) | -$67.87 M(-12.1%) |
| June 2023 | - | -$19.21 M(-11.3%) | -$77.19 M(+2.3%) |
| Mar 2023 | - | -$21.66 M(+13.7%) | -$75.43 M(+2.3%) |
| Dec 2022 | -$73.69 M(+84.7%) | -$19.05 M(+10.3%) | -$73.69 M(+0.7%) |
| Sept 2022 | - | -$17.27 M(-1.0%) | -$73.17 M(+22.1%) |
| June 2022 | - | -$17.45 M(-12.4%) | -$59.92 M(+12.7%) |
| Mar 2022 | - | -$19.93 M(+7.6%) | -$53.19 M(+33.3%) |
| Dec 2021 | -$39.91 M(-15.2%) | -$18.52 M(+359.5%) | -$39.91 M(+5.3%) |
| Sept 2021 | - | -$4.03 M(-62.4%) | -$37.89 M(-22.6%) |
| June 2021 | - | -$10.72 M(+61.3%) | -$48.96 M(+6.3%) |
| Mar 2021 | - | -$6.64 M(-59.7%) | -$46.05 M(-2.1%) |
| Dec 2020 | -$47.05 M(-3.4%) | -$16.50 M(+9.2%) | -$47.05 M(+20.4%) |
| Sept 2020 | - | -$15.10 M(+93.4%) | -$39.09 M(+3.2%) |
| June 2020 | - | -$7.81 M(+2.1%) | -$37.86 M(-10.6%) |
| Mar 2020 | - | -$7.65 M(-10.3%) | -$42.34 M(-13.1%) |
| Dec 2019 | -$48.71 M(+7.0%) | -$8.53 M(-38.5%) | -$48.71 M(+2.1%) |
| Sept 2019 | - | -$13.88 M(+13.0%) | -$47.73 M(+0.9%) |
| June 2019 | - | -$12.28 M(-12.4%) | -$47.31 M(-7.2%) |
| Mar 2019 | - | -$14.02 M(+85.7%) | -$50.98 M(+12.0%) |
| Dec 2018 | -$45.53 M(+45.1%) | -$7.55 M(-43.9%) | -$45.53 M(-4.1%) |
| Sept 2018 | - | -$13.46 M(-15.6%) | -$47.47 M(+19.4%) |
| June 2018 | - | -$15.95 M(+85.9%) | -$39.78 M(+25.4%) |
| Mar 2018 | - | -$8.58 M(-9.6%) | -$31.71 M(+1.1%) |
| Dec 2017 | -$31.38 M(+69.5%) | -$9.49 M(+64.8%) | -$31.38 M(+5.2%) |
| Sept 2017 | - | -$5.76 M(-27.0%) | -$29.84 M(+7.5%) |
| June 2017 | - | -$7.89 M(-4.3%) | -$27.76 M(+9.5%) |
| Mar 2017 | - | -$8.24 M(+3.7%) | -$25.36 M(+37.0%) |
| Dec 2016 | -$18.52 M(+103.7%) | -$7.95 M(+115.9%) | -$18.52 M(+75.2%) |
| Sept 2016 | - | -$3.68 M(-32.9%) | -$10.57 M(+53.5%) |
| June 2016 | - | -$5.49 M(+293.3%) | -$6.89 M(+252.4%) |
| Mar 2016 | - | -$1.40 M(+150.1%) | -$1.95 M(-21.7%) |
| Dec 2015 | -$9.09 M(+233.9%) | - | - |
| June 2015 | - | -$558.20 K(-42.3%) | -$2.49 M(-8.4%) |
| Mar 2015 | - | -$967.00 K(+234.1%) | -$2.72 M(-16.5%) |
| Mar 2015 | -$2.72 M(-44.7%) | - | - |
| Dec 2014 | - | -$289.40 K(-57.4%) | -$3.26 M(-29.6%) |
| Sept 2014 | - | -$679.80 K(-13.6%) | -$4.63 M(-12.6%) |
| June 2014 | - | -$786.60 K(-47.7%) | -$5.30 M(+7.6%) |
| Mar 2014 | -$4.93 M(-23.8%) | -$1.50 M(-9.4%) | -$4.93 M(+9.7%) |
| Dec 2013 | - | -$1.66 M(+23.2%) | -$4.49 M(+22.5%) |
| Sept 2013 | - | -$1.35 M(+226.0%) | -$3.67 M(-27.7%) |
| June 2013 | - | -$413.60 K(-61.3%) | -$5.07 M(-21.5%) |
| Mar 2013 | -$6.46 M(-54.5%) | -$1.07 M(+27.6%) | -$6.46 M(-26.5%) |
| Dec 2012 | - | -$836.60 K(-69.6%) | -$8.79 M(-22.5%) |
| Sept 2012 | - | -$2.75 M(+52.5%) | -$11.35 M(-0.1%) |
| June 2012 | - | -$1.81 M(-46.9%) | -$11.36 M(-20.1%) |
| Mar 2012 | -$14.21 M | -$3.40 M(+0.2%) | -$14.21 M(-10.0%) |
| Dec 2011 | - | -$3.39 M(+22.7%) | -$15.78 M(+9.3%) |
| Sept 2011 | - | -$2.76 M(-40.7%) | -$14.44 M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | -$4.66 M(-6.3%) | -$12.27 M(+38.7%) |
| Mar 2011 | -$8.85 M(+1919.5%) | -$4.97 M(+142.3%) | -$8.85 M(+114.6%) |
| Dec 2010 | - | -$2.05 M(+249.5%) | -$4.12 M(+88.5%) |
| Sept 2010 | - | -$587.00 K(-52.5%) | -$2.19 M(+24.9%) |
| June 2010 | - | -$1.23 M(+398.5%) | -$1.75 M(+299.7%) |
| Mar 2010 | -$438.00 K(+131.7%) | -$247.70 K(+111.5%) | -$438.10 K(+138.4%) |
| Dec 2009 | - | -$117.10 K(-22.8%) | -$183.80 K(+108.6%) |
| Sept 2009 | - | -$151.70 K(-293.5%) | -$88.10 K(+79.1%) |
| June 2009 | - | $78.40 K(+1087.9%) | -$49.20 K(-74.0%) |
| Mar 2009 | -$189.00 K(-63.5%) | $6600.00(-130.8%) | -$189.00 K(-43.6%) |
| Dec 2008 | - | -$21.40 K(-81.0%) | -$335.00 K(-22.7%) |
| Sept 2008 | - | -$112.80 K(+83.7%) | -$433.60 K(-15.9%) |
| June 2008 | - | -$61.40 K(-56.0%) | -$515.50 K(-0.5%) |
| Mar 2008 | -$518.20 K(+89.5%) | -$139.40 K(+16.2%) | -$518.20 K(-27.3%) |
| Dec 2007 | - | -$120.00 K(-38.4%) | -$712.40 K(+70.9%) |
| Sept 2007 | - | -$194.70 K(+203.7%) | -$416.80 K(+43.2%) |
| June 2007 | - | -$64.10 K(-80.8%) | -$291.10 K(+6.5%) |
| Mar 2007 | -$273.40 K(+42.0%) | -$333.60 K(-290.0%) | -$273.30 K(-7486.5%) |
| Dec 2006 | - | $175.60 K(-354.5%) | $3700.00(-101.5%) |
| Sept 2006 | - | -$69.00 K(+49.0%) | -$241.90 K(-6.5%) |
| June 2006 | - | -$46.30 K(-18.2%) | -$258.70 K(+34.3%) |
| Mar 2006 | -$192.60 K(+3.8%) | -$56.60 K(-19.1%) | -$192.70 K(+0.2%) |
| Dec 2005 | - | -$70.00 K(-18.4%) | -$192.40 K(+31.5%) |
| Sept 2005 | - | -$85.80 K(-535.5%) | -$146.30 K(+8.2%) |
| June 2005 | - | $19.70 K(-135.0%) | -$135.20 K(-27.2%) |
| Mar 2005 | -$185.60 K(-38.2%) | -$56.30 K(+135.6%) | -$185.60 K(-56.3%) |
| Dec 2004 | - | -$23.90 K(-68.0%) | -$424.30 K(-11.0%) |
| Sept 2004 | - | -$74.70 K(+143.3%) | -$476.90 K(+19.7%) |
| June 2004 | - | -$30.70 K(-89.6%) | -$398.50 K(+32.7%) |
| Mar 2004 | -$300.20 K(+991.6%) | -$295.00 K(+285.6%) | -$300.30 K(-3853.8%) |
| Dec 2003 | - | -$76.50 K(-2167.6%) | $8000.00(-88.2%) |
| Sept 2003 | - | $3700.00(-94.5%) | $67.80 K(+30.9%) |
| June 2003 | - | $67.50 K(+407.5%) | $51.80 K(-288.4%) |
| Mar 2003 | -$27.50 K(-198.9%) | $13.30 K(-179.6%) | -$27.50 K(-6.8%) |
| Dec 2002 | - | -$16.70 K(+35.8%) | -$29.50 K(+217.2%) |
| Sept 2002 | - | -$12.30 K(+4.2%) | -$9300.00(-158.5%) |
| June 2002 | - | -$11.80 K(-204.4%) | $15.90 K(-42.8%) |
| Mar 2002 | $27.80 K(-120.9%) | $11.30 K(+222.9%) | $27.80 K(+26.9%) |
| Dec 2001 | - | $3500.00(-72.9%) | $21.90 K(-83.6%) |
| Sept 2001 | - | $12.90 K(>+9900.0%) | $133.30 K(+91.0%) |
| June 2001 | - | $100.00(-98.1%) | $69.80 K(-152.6%) |
| Mar 2001 | -$132.80 K(<-9900.0%) | $5400.00(-95.3%) | -$132.80 K(-3.9%) |
| Dec 2000 | - | $114.90 K(-327.1%) | -$138.20 K(-45.4%) |
| Sept 2000 | - | -$50.60 K(-75.0%) | -$253.10 K(+25.0%) |
| June 2000 | - | -$202.50 K(+185.2%) | -$202.50 K(+43.7%) |
| Mar 2000 | $0.00(0.0%) | - | - |
| Mar 1999 | $0.00(-100.0%) | - | - |
| Mar 1998 | -$140.90 K(-61.1%) | -$71.00 K(+1.6%) | -$140.90 K(+101.6%) |
| Dec 1997 | - | -$69.90 K(<-9900.0%) | -$69.90 K(<-9900.0%) |
| Sept 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1997 | - | $0.00 | $0.00 |
| Mar 1997 | -$362.30 K | - | - |
FAQ
- What is VBI Vaccines annual cash flow from operations?
- What is the all time high annual CFO for VBI Vaccines?
- What is VBI Vaccines annual CFO year-on-year change?
- What is VBI Vaccines quarterly cash flow from operations?
- What is the all time high quarterly CFO for VBI Vaccines?
- What is VBI Vaccines quarterly CFO year-on-year change?
- What is VBI Vaccines TTM cash flow from operations?
- What is the all time high TTM CFO for VBI Vaccines?
- What is VBI Vaccines TTM CFO year-on-year change?
What is VBI Vaccines annual cash flow from operations?
The current annual CFO of VBIV is -$60.88 M
What is the all time high annual CFO for VBI Vaccines?
VBI Vaccines all-time high annual cash flow from operations is $27.80 K
What is VBI Vaccines annual CFO year-on-year change?
Over the past year, VBIV annual cash flow from operations has changed by +$12.81 M (+17.39%)
What is VBI Vaccines quarterly cash flow from operations?
The current quarterly CFO of VBIV is -$11.77 M
What is the all time high quarterly CFO for VBI Vaccines?
VBI Vaccines all-time high quarterly cash flow from operations is $175.60 K
What is VBI Vaccines quarterly CFO year-on-year change?
Over the past year, VBIV quarterly cash flow from operations has changed by +$7.44 M (+38.73%)
What is VBI Vaccines TTM cash flow from operations?
The current TTM CFO of VBIV is -$51.00 M
What is the all time high TTM CFO for VBI Vaccines?
VBI Vaccines all-time high TTM cash flow from operations is $133.30 K
What is VBI Vaccines TTM CFO year-on-year change?
Over the past year, VBIV TTM cash flow from operations has changed by +$26.19 M (+33.93%)